| Trial ID: | L4320 |
| Source ID: | NCT02528019
|
| Associated Drug: |
Dpp-4 Inhibiotors
|
| Title: |
Metabolic and Cardiovascular Effects of Dipeptidyl Peptidase-4 (DPP-4) or Sodium-glucose Co-transporter Type 2 (SGLT2) Inhibitors
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Effects of the DPP-4 Inhibitors or SGLT2 Inhibitors on the Protective Actions for Diabetic Complications
|
| Interventions: |
DRUG: DPP-4 inhibiotors|DRUG: SGLT2 inhibitors|DRUG: Glimepiride
|
| Outcome Measures: |
Primary: Effects of treatment on the nominal change in arterial stiffness from baseline after 6 months of treatment as measured by cardio-ankle vascular index, 6 months of treatment | Secondary: Change from baseline in subcutaneous and visceral fat volume, 6 months of treatment|Change from baseline in lipid profile including malondialdehyde-modified low-density lipoprotein and remnant-like particle cholesterol, 6 months of treatment|Change from baseline in circulating inflammatory markers, 6 months of treatment
|
| Sponsor/Collaborators: |
Sponsor: Kurume University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2015-08
|
| Completion Date: |
2018-08
|
| Results First Posted: |
|
| Last Update Posted: |
2015-08-19
|
| Locations: |
Kurume University Hospital, Kurume city, 830-0011, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT02528019
|
